Efficacy and safety of telaprevir (TVR) triple therapy in a 'real-life' cohort of 102 patients with HCV genotype 1: interim analysis after 24weeks of treatment

Werner, C. R.; Franz, C.; Egetemeyr, D. P.; Janke-Maier, P.; Malek, N. P.; Lauer, U. M.; Berg, C. P.

dc.contributor.author	Werner, Christoph Reinhold
dc.contributor.author	Franz, Christoph
dc.contributor.author	Egetemeyr, Daniel
dc.contributor.author	Janke-Maier, Petra
dc.contributor.author	Malek, Nisar Peter
dc.contributor.author	Lauer, Ulrich Manfred
dc.contributor.author	Berg, Christoph Peter
dc.date.accessioned	2014-08-06T08:26:02Z
dc.date.available	2014-08-06T08:26:02Z
dc.date.issued	2014
dc.identifier.issn	1352-0504
dc.identifier.uri	http://hdl.handle.net/10900/55236
dc.language.iso	en	en
dc.publisher	Wiley - Blackwell	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/jvh.12145	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	Efficacy and safety of telaprevir (TVR) triple therapy in a 'real-life' cohort of 102 patients with HCV genotype 1: interim analysis after 24weeks of treatment	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140610213910_00109	de_DE
utue.publikation.seiten	333-340	de_DE
utue.personen.roh	Werner, C. R.
utue.personen.roh	Franz, C.
utue.personen.roh	Egetemeyr, D. P.
utue.personen.roh	Janke-Maier, P.
utue.personen.roh	Malek, N. P.
utue.personen.roh	Lauer, U. M.
utue.personen.roh	Berg, C. P.
dcterms.isPartOf.ZSTitelID	Journal of Viral Hepatitis	de_DE
dcterms.isPartOf.ZS-Issue	5	de_DE
dcterms.isPartOf.ZS-Volume	21	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE